Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging

File(s)

Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging.pdf (257.35 KB)

Accepted version

Show more

Author(s)

Vassileva, V

Moriyama, EH

De Souza, R

Grant, J

Allen, CJ

more

Type

Journal Article

Date Issued

2008-12-09

URI

http://hdl.handle.net/10044/1/53636

DOI

https://dx.doi.org/10.1038/sj.bjc.6604803

ISSN

0007-0920

Publisher

Nature Publishing Group

Start Page

2037

End Page

2043

Journal / Book Title

British Journal of Cancer

Volume

99

Issue

12

Copyright Statement

© 2008 Cancer Research UK

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000261620100011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

bioluminescent imaging

paclitaxel

intraperitoneal therapy

sustained chemotherapy

tumour proliferation

ovarian cancer

IN-VIVO CHARACTERIZATION

STAGE-III OVARIAN

LIVE MICE

CHEMOTHERAPY

TUMOR

GROWTH

PROLIFERATION

TOMOGRAPHY

METASTASIS

TOXICITY

Animals

Body Weight

Cell Line, Tumor

Cell Survival

Disease Models, Animal

Disease Progression

Female

Humans

Injections, Intraperitoneal

Luminescent Measurements

Mice

Mice, SCID

Ovarian Neoplasms

Paclitaxel

Survival Rate

Xenograft Model Antitumor Assays

1112 Oncology And Carcinogenesis

Oncology & Carcinogenesis

Publication Status

Published